Streetbeat News

Stock Prices

CSX

CSX Corporation is expected to report a slight decline in its Q2 earnings, with analysts predicting earnings of 49 cents per share, down from 50 cents per share a year ago. The company's revenue is expected to be around $3.73 billion. Several analysts have recently upgraded their ratings and price targets for CSX, with most seeing an upside potential in the company's stock.

Portfolio Pulse from Lisa Levin

July 20, 2023 | 12:55 pm

GOSS

Gossamer Bio has announced a private placement financing of $212 million, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:54 pm

COSM

Cosmos Health has priced its $5.25 million registered direct offering and concurrent private placement at a combined price of $2.48, causing its shares to trade lower.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:52 pm

AAL

An executive from American Airlines has stated that the company continues to see an increase in customers originating from New York City. This suggests a positive trend in passenger volume for the airline.

Portfolio Pulse from Happy Mohamed

July 20, 2023 | 12:52 pm

TTOO

T2 Biosystems has received Breakthrough Device designation from the FDA for its Candida auris direct-from-blood molecular diagnostic test. This has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:51 pm

GLD

NFLX

TSLA

UUP

The number of Americans applying for unemployment benefits was lower than anticipated last week, indicating the strength of the U.S. labor market. However, investors expect the Federal Reserve to conclude its tightening cycle after hiking for the last time next week. Futures on the S&P 500 Index and the Nasdaq 100 Index were in the red due to disappointing earnings reports from Tesla Inc. and Netflix Inc. The U.S. dollar index, tracked by the Invesco DB USD Index Bullish Fund ETF, was 0.2% higher, while gold, tracked by the SPDR Gold Trust, ticked 0.1% lower.

Portfolio Pulse from Piero Cingari

July 20, 2023 | 12:49 pm

PM

Philip Morris International Inc (NYSE:PM) reported Q2 FY23 sales growth of 14.5% year-on-year to $8.97 billion, beating the analyst consensus of $8.65 billion. The company's cigarette and Heated Tobacco unit (HTU) shipment volume grew by 3.3% Y/Y, with HTUs growing by 26.6% and cigarettes declining by 0.4%. Revenue from smoke-free products increased 34.1% Y/Y to $3.2 billion. The company revised its FY23 adjusted EPS outlook from $6.10 - $6.22 to $6.13 - $6.22.

Portfolio Pulse from Shivani Kumaresan

July 20, 2023 | 12:47 pm

VSEC

VSE Corporation has priced its public offering of approximately 112.7 million shares of common stock at $48.50 per share.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:47 pm

VIR

Vir Biotechnology's shares have dropped following the failure of its Phase 2 PENINSULA trial of VIR-2482, aimed at preventing symptomatic influenza A illness, to meet primary or secondary efficacy endpoints.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:46 pm

TFC

Truist Financial reported lower-than-expected Q2 earnings results, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 12:45 pm